Pharmaceutical

Filter

Current filters:

None

Popular Filters

48 to 72 of 7204 results

Novo Nordisk shares jump on positive trial results with OG217SC

Novo Nordisk shares jump on positive trial results with OG217SC

20-02-2015

Shares of Danish diabetes care giant Novo Nordisk jumped 5% to 312.20 Danish kroner in early afternoon…

DenmarkDiabetesNovo NordiskOG217SCPharmaceuticalResearchsemaglutide

Cloud computing offers big data solutions to big pharma

Cloud computing offers big data solutions to big pharma

20-02-2015

Pharmaceutical companies spend upwards of a decade and a billion dollars to bring new drugs and therapies…

AstraZenecaCode-NExostarPharmaceuticalResearch

Astellas announces reorganization of its North American operation and business development

Astellas announces reorganization of its North American operation and business development

20-02-2015

Japanese drug major Astellas Pharma is to make organizational and personnel changes in the Americas,…

AstellasAstellas Pharma Canada IncBoardroomPharmaceuticalUSA

Ferring launches Cortiment in Europe and publishes new efficacy data

Ferring launches Cortiment in Europe and publishes new efficacy data

20-02-2015

Switzerland-headquartered privately-held pharma company Ferring has announced the European launch Cortiment…

CortimentEuropeFerringGastro-intestinalsMarkets & MarketingPharmaceuticalResearch

FDA accepts and grants priority review for Genentech's cobimetinib/Zelboraf

FDA accepts and grants priority review for Genentech's cobimetinib/Zelboraf

20-02-2015

Genentech, part of the Roche Group, says that the US Food and Drug Administration has accepted and granted…

cobimetinibGenentechOncologyPharmaceuticalRegulationRocheUSA

Lilly accepts committee recommendation to extend evacetrapib study by six months

Lilly accepts committee recommendation to extend evacetrapib study by six months

20-02-2015

US drug major Eli Lilly has accepted the recommendation of the ACCELERATE study academic executive committee…

Cardio-vascularEli LillyevacetrapibPharmaceuticalResearchUSA

EU health stakeholders set up EMVO to help fight counterfeit medicines

EU health stakeholders set up EMVO to help fight counterfeit medicines

20-02-2015

Major European health care stakeholders have taken a major step to secure the legitimate pharmaceutical…

EuropeHealthcarePharmaceuticalRegulation

Merck Serono and Sysmex Inostics open first liquid biopsy RAS biomarker testing center

Merck Serono and Sysmex Inostics open first liquid biopsy RAS biomarker testing center

20-02-2015

Merck Serono, the biopharmaceutical business of Germany’s Merck KGaA, announced today that the first…

Merck KGaAMerck SeronoOncologyPharmaceuticalResearchSpainSysmex Inostics

NICE makes preliminary recommendation on Allergan's Ozurdex for macular edema

NICE makes preliminary recommendation on Allergan's Ozurdex for macular edema

20-02-2015

The UK’s National Institutes of Health and Care Excellence has recommended Ozurdex (dexamethasone),…

AllerganDexamethasoneOphthalmicsOzurdexPharmaceuticalRegulationUK

NICE gives green light to Bayer’s Eylea for DME

20-02-2015

In a preliminary recommendation issued today, England’s health costs watchdog the National Institute…

BayerEyleaOphthalmicsPharmaceuticalPricingRegulationUK

Move of Bayer’s Olivier Brandicourt to become Sanofi CEO confirmed

Move of Bayer’s Olivier Brandicourt to become Sanofi CEO confirmed

20-02-2015

Confirming what the media had been saying most of the week, French pharma major Sanofi late yesterday…

BayerBoardroomManagementPharmaceuticalSanofi

Astellas' once-daily Advagraf demonstrates superiority to twice-daily immediate release

Astellas' once-daily Advagraf demonstrates superiority to twice-daily immediate release

20-02-2015

Japanese drug major Astellas has published results of a study demonstrating that early and sustained…

AdvagrafAstellasNephrology and HepatologyPharmaceuticalResearch

Kymab appoints Anne Hyland as chief financial officer

Kymab appoints Anne Hyland as chief financial officer

19-02-2015

Kymab, a pharma company based in Cambridge, UK, focusing on monoclonal antibodies, has appointed Anne…

BiotechnologyBoardroomKymabPharmaceuticalUK

NICE sets too high a QALY cost for NHS drugs, new research claims

NICE sets too high a QALY cost for NHS drugs, new research claims

19-02-2015

The price the National Heath Service in England agrees to pay for new medicines is too high, causing…

HealthcarePharmaceuticalPricingUK

UPDATE: New study shows Regeneron’s Eylea is superior to rivals in DME

UPDATE: New study shows Regeneron’s Eylea is superior to rivals in DME

19-02-2015

US biotech Regeneron Pharmaceuticals today announced results from a study which show Eylea (aflibercept)…

AvastinEyleaLucentisOphthalmicsPharmaceuticalRegeneron PharmaceuticalsResearchUSA

Indian drugmaker Venus sets out pre-budget expectations

Indian drugmaker Venus sets out pre-budget expectations

19-02-2015

The Union Finance Minister should take his government’s “Make in India” campaign to the next level…

FinancialIndiaPharmaceuticalPoliticsResearchVenus Remedies

Ferring Pharma acquires two Ph III-ready orthobiologics from BioSET

Ferring Pharma acquires two Ph III-ready orthobiologics from BioSET

19-02-2015

Privately-held Switzerland-headquartered Ferring Pharmaceuticals has acquired the assets of USA-based…

AmplexFerring PharmaceuticalsLicensingPharmaceuticalPrefixSwitzerland

NICE final draft guidance recommends Norgine's Targaxan

NICE final draft guidance recommends Norgine's Targaxan

19-02-2015

The UK’s National Institute for Health and Care Excellence has published its final draft guidance recommending…

Nephrology and HepatologyNeurologicalNorginePharmaceuticalRegulationTargaxanUK

Pharma violates own marketing regulations, Swedish study alleges

Pharma violates own marketing regulations, Swedish study alleges

19-02-2015

A new report from Lund University in Sweden claims to show how the pharmaceutical industry, time and…

Markets & MarketingPharmaceuticalRegulationSwedenUK

Actavis’ fourth-qtr 2014 beats expectations

Actavis’ fourth-qtr 2014 beats expectations

18-02-2015

Ireland-headquartered generics major Actavis posted better-than-expected fourth-quarter and full-year…

AccountancyActavisAllerganFinancialForest LaboratoriesGenericsPharmaceuticalThomson ReutersUSA

Former pharma execs set up financing strategy partnership

Former pharma execs set up financing strategy partnership

18-02-2015

Three former pharma and health care executives have formed a new partnership to provide strategic support…

Business FinanceFinancialnext20PharmaceuticalUSA

Sanofi collaborates with Lead Pharma for autoimmune disease development

Sanofi collaborates with Lead Pharma for autoimmune disease development

18-02-2015

French pharma major Sanofi has entered into a research collaboration and license agreement with privately-held…

Anti-Arthritics/RheumaticsLead PharmaLicensingPharmaceuticalResearchSanofi

Use of generics key to glaucoma medicine adherence, study says

Use of generics key to glaucoma medicine adherence, study says

18-02-2015

A potential solution to resolve patient non-adherence in glaucoma treatment is switching to generic drugs,…

Bimatoprost Ophthalmic Solution 0.03% for GlaLatanoprost OphthalmicOphthalmicsPharmaceuticalPricingResearchUSA

VBL Therapeutics shares slide as it ends VB-201 development in two indications

VBL Therapeutics shares slide as it ends VB-201 development in two indications

18-02-2015

Shares in Israeli drugmaker VBL Therapeutics dropped up to 55% after it said that it would discontinue…

Gastro-intestinalsIsraelOncologyPharmaceuticalResearchVBL Therapeutics

48 to 72 of 7204 results

COMPANY SPOTLIGHT

Menarini

Back to top